Tesla CEO Elon Musk said on Tuesday that early production rate of the companys Cybercab robotaxi and its humanoid robot Optimus will be "agonizingly slow" before accelerating over time.
The stocks that refuse to drop in a tough market are often the ones that will lead the next leg higher. By utilizing relative strength, investors can identify the best long opportunities.
Join us as we evaluate Insulets potential in the diabetes management market. With a unique product offering and strong growth, could this stock be your next big investment?
Some of the biggest Chinese firms listed in Hong Kong are busy buying back their own shares, seeking to shore up investor confidence in their cooling stock prices.
South Korean equities remain attractive despite a record-breaking rally, with a corporate reform drive modeled on Japan’s playbook seen delivering faster gains for shareholders, according to First Eagle Investment Management.
Image source: The Motley Fool.DateTuesday, January 20, 2026 at 5:30 p.m. ETCall participantsChairman and Chief Executive Officer — Harris H. SimmonsChief Financial Officer — Ryan G. RichardsPresident and Chief Operating Officer — Scott J. McClainChief Credit Officer — Derek A. StewartDirector of Investor Relations — Shannon L. DrageNeed a quote from a Motley Fool analyst? Email pr@fool.comTakeawaysNet Income -- $262 million, up 19% sequentially and 31% year over year, attributed to higher r...
Veronika the Austrian cow adapts the placement of a tool depending where on her body she has an itch, and challenges assumptions about cattle smarts in the process.
The looming global trade war with Europe might hit home very soon. The tariff threats escalating out of the Greenland dispute could end up hurting your wallet later this year — and not just because of the higher prices you’d pay for French champagne and other European goods. Short-term interest ...
Meta Platforms massive AI capex, custom chips and mega clusters contrast with Super Micro Computers cash strain, giving META a diversified edge in AI infrastructure.
Renewed transatlantic trade tensions and a complex geopolitical landscape heighten U.S. economic volatility, prompting investors to turn to global equity funds.
AI data-center connectivity favors Lumentum Holdings over Marvell Technology as optical demand, margins, and revenue surge while balance-sheet risk clouds rivals.
NFLX beats Q4 earnings and revenue estimates, crosses 325 million paid members, and sees strong gains from ads, pricing, and a blockbuster content slate.
Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
The Q4 earnings season is off to a solid start, with the growth pace accelerating and most management teams painting a stable-to-positive outlook for their businesses.
The Q4 earnings season is off to a solid start, with the growth pace accelerating and most management teams painting a stable-to-positive outlook for their businesses.
Electronics manufacturer Jabil has made a strategic minority investment in US-based Eagle Harbor Technologies, operating under the name EHT Semi, and entered into a manufacturing collaboration focused on RF and pulsed-power systems for advanced semiconductor manufacturing.
Ondas appears to edge out Red Cat Holdings as its fast-scaling OAS platform lifts backlog, boosts 2026 revenue targets and supports a stronger balance sheet.
CLS heads into Q4 earnings after rolling out AI-focused storage solution and 1.6TbE switches, but weakness in the ATS segment and a premium valuation raise caution.
General Motors surges past Ferrari as U.S. leadership, a China turnaround, and fast-growing software revenues tilt the auto stock matchup in its favor.
Trump didnt mention NATO until after he had been speaking more than half an hour, and at that point he said he has been "treated very badly" by the alliance.
Zacks Media Conglomerates industry players like SPHR, LION and MSGE gain from the rising demand for high-speed Internet and increased media consumption.
Progress Software tops Q4 earnings estimates as revenue jumps 18% year over year, ARR grows, and upbeat fiscal 2026 guidance sends shares up nearly 9% in pre-market.
Roche more than doubles Genentechs Holly Springs biomanufacturing investment to approximately $2B, boosting U.S. supply-chain resilience and metabolic drug production.